Navigation Links
Improved Testing for Hepatitis B Virus From Roche
Date:12/8/2008

PLEASANTON, Calif., Dec. 8 /PRNewswire/ -- Roche Molecular Diagnostics announced today that it has received CE Mark certification for its new COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HBV Test v2.0, allowing it to be sold for clinical use in the European Union. This highly sensitive test offers Roche's fully automated real-time PCR technology to achieve a broad dynamic range for the quantitative detection of hepatitis B virus (HBV) DNA in patient plasma and serum. According to the World Health Organization, approximately 2 billion people worldwide and about 350 million live with chronic HBV infection and are at risk of developing end stage liver disease and liver cancer.(1)

"It is critical to monitor the levels of circulating hepatitis B virus as an indicator as to when hepatitis B therapies should be started, and to determine response to treatment," said Teresa Wright, M.D., Chief Medical Officer at Roche Molecular Diagnostics. "This test enables doctors to optimize patient treatment with standardized viral load measurements and enables laboratories to test efficiently with improved automation."

Hepatitis B viral load testing enables clinicians to quantify the amount of hepatitis B virus in a patient's blood, select patients for treatment, predict and assess individual responses to therapy and assess patients' responses to therapy when they undergo treatment.

About the COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HBV Test v2.0

The Roche COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HBV Test v2.0 can detect genotypes A-H and pre-core mutants. It offers a broader dynamic range than previous generation tests, from as low as 20 IU/mL and as high as 1.7E+08 IU/mL, enabling physicians to improve viral load monitoring. The assay offers both serum and plasma specimen type and only uses 650 microliters sample processing volume.

This test is designed for use on Roche's automated platform that
'/>"/>

SOURCE Roche Molecular Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Towards improved immunotherapy
2. Physicists receive patent for improved cancer therapy device
3. Health study in northern Uganda calls for improved services for internally displaced persons
4. Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008
5. Advanced lung cancer patients see improved, progression-free survival
6. Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
7. Dual treatment for stroke leads to improved recovery rates, reduced mortality
8. America Hears Introduces New and Improved Hearing-Aid Programming Software
9. Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009
10. Dairy Veterinarians Highlight Need for Improved Methods for Detecting Mastitis
11. Improved rodent trials can speed cancer drug development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... cell disease, a condition characterized by deformed and ... most common genetic blood disorders affecting millions of ... Americans.(1) Research presented today at the 51st Annual ... intriguing studies on the acute danger that the ... disorder, evaluations of both new and standard treatments ...
(Date:12/6/2009)... Internet Sleep Disorders information and Treatment site ... sleep problems with herbal or natural sleep aids ... ,insomnia remedies for a good cause. The submissions ... Natural Sleep Aids ,Encyclopedia, by YOU, to be ... The site will donate 100% of the proceeds ...
(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...
(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2
... WEDNESDAY, Nov. 14 (HealthDay News) -- A protein that may ... to be a biomarker that indicates severe asthma. And it ... according to new research. , Reporting in the Nov. 15 ... Yale University researchers said that people with severe asthma were ...
... 34 years shows parental history, overweight are markers for ... The development of type 2 diabetes in adults can ... that,s followed a group of 814 children and adults ... Center found that parental history of diabetes, as well ...
... Community Hospital of Long Beach (CHLB) is entering to win a ... The hospital that receives the most votes will win the ... taking place NOW through December 31, ... ,Community Hospital of Long Beach, from the drop ...
... prepared testimony of NCPA president Steve Giroux before the ... the counter,availability of certain drugs., "Hello, I am ... and a pharmacist from Middleport, New York., NCPA ... public meeting to,explore the public health benefit of certain ...
... Plastic Surgery Procedures, LAS VEGAS, Nov. 14 ... raised questions about the safety of plastic,surgery. The factors ... concerns over her physician,s lack of board certification and,his ... should,be reassured that Donda West,s tragic outcome is unusual," ...
... donors share in success, Governor Phil Bredesen ... Consortium headquarters, Chili,s Care Center culmination of ... care, MEMPHIS, Tenn., Nov. 14 St. ... celebrated the national,grand opening of the Chili,s Care ...
Other Medicine News:Health News:Defensive Protein Linked to Asthma 2Health News:Defensive Protein Linked to Asthma 3Health News:Adult Type 2 Diabetes Can Be Predicted in Childhood 2Health News:Community Hospital of Long Beach - Help Us Win an MRI Scanner! 2Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 2Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 3Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 4Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 5Health News:Guide to Minimizing Your Plastic Surgery Risks 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4
(Date:12/4/2009)... Dec. 4 The U.S. Food and ... form as an option for the treatment of schizophrenia ... disorder in adolescents aged 13-17 years old. ,, ... into consideration the increased potential for weight gain and ...
(Date:12/4/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Principal investigators will discuss the data presentations surrounding carfilzomib ... the 51st American Society of Hematology (ASH) Annual Meeting. ... a.m. ET on Monday, December 7, 2009. The ...
(Date:12/4/2009)... Chemistry World recently highlighted a new report ... America ( PhRMA ) that identifies 97 new drugs ... The report found that the 97 products in ... either in human clinical trials or awaiting approval by the ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Management Health Solutions Inc to Exhibit at HFMA ANI 47574 1Management Health Solutions Inc to Exhibit at HFMA ANI 47574 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 1HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 3HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 4New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 1New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 2
... Pa. and LYON, France, Aug. 1 Sanofi,Pasteur, ... vaccine (Fluzone(R), Influenza Virus Vaccine) in the United,States ... doses of influenza,vaccine began shipping this week following ... Food and Drug Administration (FDA) on,July 14, 2008., ...
... CLL Meets ... Primary Endpoint, COPENHAGEN, ... GSK) announced today positive top-line,results from an interim analysis of the ... chronic lymphocytic,leukemia (CLL) patients with high unmet medical need. At the ...
Other Medicine Technology:Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 5Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 2Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 3Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 4Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 5Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study 6
... The RapidPCP test is an ... test. It is,designed for qualitative determination ... above,a cut-off level of 25 ng/mL. ... in the point of care location,and ...
The RapidMTD test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of methadone in human urine specimens above a,cut-off level of 300 ng/mL. The a...
The RapidBARBITURATE test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of barbiturates and in human urine specimens above a cut-off level of 3...
... With membrane parasite ... and cytoplasm as antigen. ... different antigens than the ... possible to use two ...
Medicine Products: